FDA has approved zanidatamab (Ziihera, Jazz Pharmaceuticals, Inc.) as monotherapy for previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC)
Among pregnant women whose height was <154 cm, the risk of postpartum development of pulmonary edema gradually decreased with increasing height (OR = 0.65, P = .0104)
The management of pulmonary aspiration risk for patients on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) during general anesthesia or deep sedation is an evolving area of concern
Last month, the US Food and Drug Administration (FDA) approved three new drugs, as well as a potentially practice-changing cancer screening tool, and expanded indications for two agents.
The AHA has issued a new scientific statement on the link between heart failure, atrial fibrillation, and coronary heart disease and the increased risk for cognitive impairment and dementia.
Participants with T2D who were able to stop insulin up to 12 months after receiving the novel recellularization via electroporation therapy combination with Semaglutide